These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Culotte versus the novel nano-crush technique for unprotected complex bifurcation left main stenting: difference in procedural time, contrast volume and X-ray exposure and 3-years outcomes. Rigatelli G; Zuin M; Vassilev D; Dinh H; Giatti S; Carraro M; Zanon F; Roncon L; Dung HT Int J Cardiovasc Imaging; 2019 Feb; 35(2):207-214. PubMed ID: 30446919 [TBL] [Abstract][Full Text] [Related]
4. Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis. Rigatelli G; Zuin M; Dell'Avvocata F; Nguyen T Ther Adv Cardiovasc Dis; 2018 Jun; 12(6):161-168. PubMed ID: 29589515 [TBL] [Abstract][Full Text] [Related]
5. Optimal Site for Proximal Optimization Technique in Complex Coronary Bifurcation Stenting: A Computational Fluid Dynamics Study. Zuin M; Rigatelli G; Chiastra C Cardiovasc Revasc Med; 2020 Jul; 21(7):826-832. PubMed ID: 31866275 [TBL] [Abstract][Full Text] [Related]
6. Complex coronary bifurcation revascularization by means of very minimal crushing and ultrathin biodegradable polymer DES: Feasibility and 1-year outcomes of the "Nano-crush" technique. Rigatelli G; Dell'Avvocata F; Zuin M; Vassiliev D; Mazza A; Dinh HD Cardiovasc Revasc Med; 2017; 18(1):22-27. PubMed ID: 27566904 [TBL] [Abstract][Full Text] [Related]
7. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944 [TBL] [Abstract][Full Text] [Related]
8. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Worthley S; Hendriks R; Worthley M; Whelan A; Walters DL; Whitbourn R; Meredith I Cardiovasc Revasc Med; 2015; 16(7):413-7. PubMed ID: 26346023 [TBL] [Abstract][Full Text] [Related]
17. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques. Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082 [TBL] [Abstract][Full Text] [Related]
18. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting. Pan M; Medina A; Suárez de Lezo J; Romero M; Segura J; Martín P; Suárez de Lezo J; Hernandez E; Mazuelos F; Ojeda S Catheter Cardiovasc Interv; 2012 Dec; 80(7):1165-70. PubMed ID: 22511299 [TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607 [TBL] [Abstract][Full Text] [Related]